LEADER 04043nam 22006135 450 001 9910373910603321 005 20250609110111.0 010 $a981-329-271-7 024 7 $a10.1007/978-981-32-9271-0 035 $a(CKB)4100000009939747 035 $a(MiAaPQ)EBC5987450 035 $a(DE-He213)978-981-32-9271-0 035 $a(PPN)248602020 035 $a(MiAaPQ)EBC6220598 035 $a(EXLCZ)994100000009939747 100 $a20191129d2019 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aDepressive Disorders: Mechanisms, Measurement and Management /$fedited by Yiru Fang 205 $a1st ed. 2019. 210 1$aSingapore :$cSpringer Singapore :$cImprint: Springer,$d2019. 215 $a1 online resource (298 pages) 225 1 $aAdvances in Experimental Medicine and Biology,$x0065-2598 ;$v1180 311 08$a981-329-270-9 327 $aAn Overview of Depressive Disorder -- Genetic advance in depressive disorder -- Neuroimaging advance in major depressive disorder -- Neuroimmune advance in depressive disorder -- Neurophysiologic advance in major depressive disorder -- Biological rhythms advance in depressive disorder -- Advances in molecular and circuitry mechanisms of depressive disorder ? A focus on lateral habenula -- Advance in stress for depressive disorder -- Advance in diagnosis of major depressive disorders -- Standardized treatment strategy for depressive disorder -- Optimized treatment strategy for depressive disorder -- Individualized treatment strategy for depressive disorder -- Psychological Treatment for Depression -- Internet-based management for depressive disorder -- Potential Anti-depressive treatment maneuvers from bench to bedside. 330 $aThis book offers a state-of-the-art report on recent discoveries concerning the basic and clinical, neuroscientific and psychiatric findings in depression research. Depressive disorder is a severe and recurrent brain disorder that can manifest in depressive mood, somatic symptoms and cognitive impairment. The underlying mechanisms of depressive disorder and its clinical practice are subjects of long-standing interests. This book is a biologically plausible and multilevel theory which describes neural, physiological, molecular and genomic mechanisms that drive depression pathogenesis, as well as navigates the clinical practice and management for depressive disorder. It mainly describes advances made over the past 20 years on the neural, molecular, neuroimaging, physiology, pathophysiology, pharmacology and internet-based measurement and management of depressive disorder. It will help postgraduate students and academic researchers to get either basic or clinical picture of depressive disorder. Also, it may benefit pharmaceutical companies for developing novel drugs to treat this disease. . 410 0$aAdvances in Experimental Medicine and Biology,$x0065-2598 ;$v1180 606 $aNeurosciences 606 $aPsychiatry 606 $aMolecular biology 606 $aNeurosciences$3https://scigraph.springernature.com/ontologies/product-market-codes/B18006 606 $aPsychiatry$3https://scigraph.springernature.com/ontologies/product-market-codes/H53003 606 $aMolecular Medicine$3https://scigraph.springernature.com/ontologies/product-market-codes/B1700X 606 $aDepressió psíquica$2thub 608 $aLlibres electrònics$2thub 615 0$aNeurosciences. 615 0$aPsychiatry. 615 0$aMolecular biology. 615 14$aNeurosciences. 615 24$aPsychiatry. 615 24$aMolecular Medicine. 615 7$aDepressió psíquica 676 $a616.8527 702 $aFang$b Yiru$4edt$4http://id.loc.gov/vocabulary/relators/edt 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910373910603321 996 $aDepressive Disorders: Mechanisms, Measurement and Management$92140614 997 $aUNINA